Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities (Q39971422)
Jump to navigation
Jump to search
scientific article published in July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities |
scientific article published in July 2008 |
Statements
1 reference
Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities (English)
1 reference
S Meidute Abaraviciene
1 reference
I Lundquist
1 reference
1 July 2008
1 reference
1 reference
2256-2265
1 reference
Identifiers
1 reference